IP Library Granted Patent US 7,744,673
Granted Patent B2
US 7,744,673 · App. 11/876,338 · Granted Jun 29, 2010

Hollow sphere metal oxides

Assignee: STC.UNM
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,744,673
App. No.
11/876,338
Granted
Jun 29, 2010
Kind
B2
Abstract

In accordance with invention, there are methods for fabricating hollow spheres and nanofoams. The method for making hollow spheres can include providing a homogeneous precursor solution including a first solvent and one or more anhydrous precursor species and forming aerosol droplets having a first size distribution using the homogeneous precursor solution in an anhydrous carrier gas. The method can also include transporting the aerosol droplets through an aerosol reactor including a reactant to form a plurality of hollow spheres, wherein each of the plurality of hollow spheres can be formed by one or more chemical reactions occurring at a surface of the aerosol droplet. The method can further include controlling size and thickness of the hollow spheres by one or more of the precursor solution concentration, aerosol droplet size, temperature, residence time of the aerosol droplets in the aerosol reactor, and the reactant distribution in the aerosol reactor.

Claims (33)

1. A method for fabricating hollow spheres comprising:

providing a homogeneous precursor solution comprising a first hydrophobic solvent and one or more anhydrous precursor species;

forming aerosol droplets having a first size distribution using the homogeneous precursor solution in an anhydrous carrier gas;

transporting the aerosol droplets through an aerosol reactor containing a reactant to form a plurality of hollow spheres, wherein each of the plurality of hollow spheres is formed by one or more chemical reactions occurring at a surface of the aerosol droplet; and

controlling size and thickness of the hollow spheres by one or more of the precursor solution concentration, aerosol droplet size, temperature, residence time of the aerosol droplets in the aerosol reactor, and the reactant distribution in the aerosol reactor.

2. The method of claim 1 , wherein the first hydrophobic solvent comprises one or more anhydrous volatile inert hydrophobic solvents and the reactant comprises water.

3. The method of claim 2 , wherein the precursor species comprises one or more of metal alkoxides and metal chlorides.

4. The method of claim 3 , wherein the precursor species comprises one or more of tin, germanium, titanium, silicon, zinc, zirconium, cadmium, lead, and mercury.

5. The method of claim 3 , wherein the hollow sphere comprises a metal oxide shell.

6. The method of claim 5 further comprising converting the metal oxide shell to a metal shell.

7. The method of claim 1 further comprising annealing the plurality of hollow spheres to convert the hollow spheres from an amorphous state to a multi-crystalline state.

8. The method of claim 1 , wherein the first hydrophobic solvent comprises one or more anhydrous volatile inert hydrophobic solvents and the reactant comprises one or more of hydrogen sulfide, volatile sulfides, hydrogen, and aldehydes.

9. The method of claim 8 , wherein the hollow sphere comprises one or more of a metal shell and a metal sulfide shell.

10. The method of claim 9 , wherein the metal is selected from the group consisting of silver, copper, gold, platinum, palladium, zinc, zirconium, cadmium, lead, and mercury.

11. The method of claim 1 , wherein the aerosol reactor further contains a catalyst.

12. The method of claim 11 , wherein the catalyst comprises one or more of ammonia, organic amines, hydrogen chloride, and organic acids.

13. The method of claim 1 , wherein the homogeneous precursor solution further comprises one or more pharmaceutical compositions.

14. The method of claim 13 , wherein the one or more hollow spheres comprise one or more pharmaceutical compositions.

15. The method of claim 1 , wherein the precursor species comprises one or more of quantum dots, magnetic nanoparticles, and preformed nanocrystallines.

16. The method of claim 15 , wherein the one or more hollow spheres comprise one or more of quantum dots, magnetic nanoparticles, and preformed nanocrystallines.

17. A method for fabricating nanofoam comprising:

providing a homogeneous precursor solution comprising a first hydrophobic solvent and one or more anhydrous precursor species;

forming aerosol droplets having a first size distribution using the homogeneous precursor solution in an anhydrous carrier gas;

transporting the aerosol droplets through an aerosol reactor containing a reactant, wherein one or more chemical reactions occurs at a surface of the aerosol droplet to form partially consolidated hollow sphere; and

aggregating partially consolidated hollow spheres to form nanofoam.

18. The method of claim 17 , wherein the first hydrophobic solvent comprises one or more anhydrous volatile inert hydrophobic solvents and the reactant comprises water.

19. The method of claim 18 , wherein the precursor species comprises one or more of metal alkoxides and metal chlorides.

20. The method of claim 19 , wherein the precursor species comprises one or more of tin, germanium, titanium, silicon, zinc, zirconium, cadmium, lead, and mercury.

21. The method of claim 19 , wherein the nanofoam comprises one or more of a metal oxide shell and a metal shell.

22. The method of claim 17 , wherein the first hydrophobic solvent comprises one or more anhydrous volatile inert hydrophobic solvents and the reactant comprises one or more of hydrogen sulfide, volatile sulfides, hydrogen, and aldehydes.

23. The method of claim 19 , wherein the nanofoam comprises one or more of a metal shell and a metal sulfide shell.

24. The method of claim 22 , wherein the metal is selected from the group consisting of silver, copper, gold, platinum, palladium, zinc, zirconium, cadmium, lead, and mercury.

25. The method of claim 17 , wherein the nanofoam comprise one or more of pharmaceutical composition, quantum dots, magnetic nanoparticles, and preformed nanocrystallines.

Assignments (3)
CONFIRMATORY LICENSE Recorded Aug 5, 2010
From: UNIVERSITY OF NEW MEXICO ALBUQUERQUE
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 024792/0190 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 27, 2009
From: JIANG, XINGMAO; BRINKER, C. JEFFREY
To: REGENTS OF THE UNIVERSITY OF NEW MEXICO
Reel/Frame 022463/0277 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 27, 2009
From: REGENTS OF THE UNIVERSITY OF NEW MEXICO
To: STC.UNM
Reel/Frame 022463/0327 →
Continuity (2)
Provisional Application 6085493300 · Oct 27, 2006
Related Publication 20080210053A1 · Sep 4, 2008